The Scientific Council is responsible for the implementation of the scientific engagement policy, the co-ordination of all the scientific activities and for ensuring a consolidated reporting of the results in line with the scientific engagement policy.

Chair: Uulke van der Heide, Medical Physicist, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NL)

President: Matthias Guckenberger, Radiation Oncologist, University Hospital Zurich (CH) 

 

Radiotherapy & Oncology Editor-in-Chief: Pierre Blanchard, Radiation Oncologist, Gustave Roussy Institute (FR)

ctRO Editor-in-Chief: Cihan Gani, Radiation Oncologist, Tübingen University Hospital (DE)

phiRO Editor-in-Chief: Ludvig Muren, Medical Physicist, Aarhus University Hospital (DK) 

tipsRO Editor-in-Chief: Michelle Leech, RTT, Trinity College Dublin (IE) 

 

Clinical Committee Representative: Piet Ost, Radiation Oncologist, Iridium Netwerk Antwerp (BE)

Physics Committee Representative: Daniela Thorwarth, Medical Physicist, University of Tübingen (DE)

Biology Committee Representative: Brita Singer Sørensen, Biologist, Aarhus University (DK) 

RTT Committee Representative: Yat Man Tsang, RTT, Princess Margaret Cancer Center (CA)

GEC-ESTRO Committee Representative: Ina Jürgenliemk-Schulz, Radiation Oncologist, University Medical Center Utrecht (NL)

 

Guidelines Committee Chair: Thomas Zilli, Radiation Oncologist, Oncology Institute of Southern Switzerland, EOC (CH)

ROSQC Chair: Petra Reijnders-Thijssen, RTT, Maastro (NL) 

 

Board Representative: Marianne Aznar, Medical Physicist, University of Manchester (UK) 

Board Representative: Kerstin Borgmann, Biologist, University Medical Center Hamburg-Eppendorf (DE) 

 

EPTN task force Co-Chair: Damien Weber, Clinical Oncologist, Paul Scherrer Institute (CH)

HERO Co-Chair: Ajay Aggarwal, Clinical Oncologist, King's College London (UK)

HERO Co-Chair and E²R PI: Yolande Lievens, Radiation Oncologist, Ghent University Hospital and Ghent University (BE)